Bard Financial Services, Inc. Abb Vie Inc. Transaction History

Bard Financial Services, Inc.

$840 Million
Q3 2024

A detailed history of Bard Financial Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Bard Financial Services, Inc. holds 69,255 shares of ABBV stock, worth $12.3 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

69,255

Previous 24,430 183.48%

Holding current value

$12.3 Million

Previous $4.82 Million 183.5%

% of portfolio

1.63%

Previous 1.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 20, 2024	BUY	$163.84 - $199.33 $7.34 Million - $8.93 Million	44,825 Added 183.48%	69,255 $13.7 Million
Q3 2024 Oct 04, 2024	SELL	$163.84 - $199.33 $8.25 Million - $10 Million	-50,325 Reduced 67.32%	24,430 $4.82 Million
Q2 2024 Jul 09, 2024	SELL	$154.79 - $180.76 $54,176 - $63,266	-350 Reduced 0.47%	74,755 $12.8 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $198,144 - $223,156	1,440 Added 1.95%	75,105 $11.6 Million
Q3 2023 Oct 16, 2023	BUY	$133.59 - $154.65 $92,177 - $106,708	690 Added 0.95%	73,665 $11 Million
Q2 2023 Jul 11, 2023	SELL	$132.51 - $164.9 $132,510 - $164,900	-1,000 Reduced 1.35%	72,975 $9.83 Million
Q1 2023 Apr 26, 2023	SELL	$144.61 - $166.54 $36,152 - $41,635	-250 Reduced 0.34%	73,975 $11.8 Million
Q4 2022 Jan 25, 2023	SELL	$138.31 - $165.87 $20,054 - $24,051	-145 Reduced 0.19%	74,225 $12 Million
Q3 2022 Oct 26, 2022	SELL	$134.21 - $153.93 $33,552 - $38,482	-250 Reduced 0.34%	74,370 $9.98 Million
Q2 2022 Jul 06, 2022	SELL	$137.62 - $174.96 $68,810 - $87,480	-500 Reduced 0.67%	74,620 $11.4 Million
Q1 2022 Apr 13, 2022	BUY	$131.98 - $163.75 $26,395 - $32,750	200 Added 0.27%	75,120 $12.2 Million
Q4 2021 Jan 24, 2022	BUY	$107.43 - $135.93 $145,030 - $183,505	1,350 Added 1.83%	74,920 $10.1 Million
Q3 2021 Oct 15, 2021	SELL	$106.4 - $120.78 $93,100 - $105,682	-875 Reduced 1.18%	73,570 $7.94 Million
Q2 2021 Jul 13, 2021	BUY	$105.21 - $117.21 $60,495 - $67,395	575 Added 0.78%	74,445 $8.39 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $332,986 - $366,578	-3,255 Reduced 4.22%	73,870 $7.99 Million
Q4 2020 Mar 26, 2021	BUY	$80.49 - $108.67 $6.21 Million - $8.38 Million	77,125 New	77,125 $8.26 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bard Financial Services, Inc. with notifications on news.

Account

Bard Financial Services, Inc. Abb Vie Inc. Transaction History